This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A patient with renal failure is undergoing chronic hemodialysis. The patient's hemoglobin is 10.6 ... (Read 91 times)

rlane42

  • Hero Member
  • *****
  • Posts: 594
on: Jul 23, 2018
A patient with renal failure is undergoing chronic hemodialysis. The patient's hemoglobin is 10.6 gm/dL. The provider orders sodiumferric gluconate complex (SFGC Ferrlecit). What will the nurse expect to do?
 
  a. Administer the drug intravenously with erythropoietin.
  b. Give a test dose before each administration of the drug.
  c. Have epinephrine on hand to treat anaphylaxis if needed.
  d. Infuse the drug rapidly to achieve maximum effects quickly.

Question 2

A nurse is caring for a patient with hemophilia A who has been admitted for bleeding into the knee joint.
 
  The prescriber has ordered intravenous factor VIIa (NovoSeven RT). A nursing student wants to know why this patient is not receiving factor VIII. Which statement by the nurse is correct?
  a. Factor VIIa is stronger than factor VIII and will work faster.
  b. Factor VIII is used for prophylaxis, and factor VIIa is used for acute episodes.
  c. Factor VIIa is used when patients develop antibodies against factor VIII.
  d. Factor VIIa provides immune tolerance therapy so that factor VIII will be more effective.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

amanda_14

  • Sr. Member
  • ****
  • Posts: 342
Reply #1 on: Jul 23, 2018
Answer to Question 1

ANS: A
SFGC is given parenterally for iron deficiency anemia in patients undergoing chronic hemodialysis. It is always used in conjunction with erythropoietin to stimulate production of red blood cells (RBCs). A test dose is given only with the initial dose and is not necessary with subsequent doses. Anaphylaxis is not a common side effect. The drug should be infused slowly.

Answer to Question 2

ANS: C
When patients develop antibodies against factor VIII, activated factor VII is used, because it has the same actions as factor VIII. Factor VIIa is not stronger than factor VIII. It is not used for prophylaxis only. Immune tolerance therapy describes the use of repeated administration of factor replacement products to eliminate inhibitor production.


rlane42

  • Hero Member
  • *****
  • Posts: 594
Reply #2 on: Jul 23, 2018
Thank you!


amanda_14

  • Sr. Member
  • ****
  • Posts: 342
Reply #3 on: Jul 23, 2018
Always glad to help...


« previous next »
 

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

Although the Roman numeral for the number 4 has always been taught to have been "IV," according to historians, the ancient Romans probably used "IIII" most of the time. This is partially backed up by the fact that early grandfather clocks displayed IIII for the number 4 instead of IV. Early clockmakers apparently thought that the IIII balanced out the VIII (used for the number 8) on the clock face and that it just looked better.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

During the twentieth century, a variant of the metric system was used in Russia and France in which the base unit of mass was the tonne. Instead of kilograms, this system used millitonnes (mt).

Did you know?

Although puberty usually occurs in the early teenage years, the world's youngest parents were two Chinese children who had their first baby when they were 8 and 9 years of age.

Pathophysiology of renal diseases and hypertension Pathophysiology of renal diseases and hypertension
Patient teaching: female breast assessment Patient teaching: female breast assessment
Foley catheter with balloon in the bladder of a male patient. Foley catheter with balloon in the bladder of a male patient.
A partnership between the patient and the health care provider. A partnership between the patient and the health care provider.
Gingival enlargement in a patient taking phenytoin. Gingival enlargement in a patient taking phenytoin.
Video: Depolarization of the SA node, Action potentials of the myocardium & ANS effects

For a complete list of videos, visit our video library